Hypoxia Modulates Nanovesicle Phenotype and Angiogenic Function From Human Pluripotent Stem Cells
PROTEOMICS · 2026-07 · 26 (7) · 84-97
DOI: 10.1002/pmic.70129 ↗Kurz gefasst
Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 05.04.2026. Verfasst von Jonathan Lozano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Neovascularization, Physiologic, Induced Pluripotent Stem Cells, Angiogenesis. Die Arbeit nennt 113 Literaturangaben. Gefördert von: National Heart Foundation of Australia.
Abstract (Originalsprache)
Nanovesicles (NVs)—generated directly from donor cells—have emerged as important mediators of intercellular communication, drug delivery devices, and in therapeutic applications, including regenerative biology. Top‐down strategies to enhance the potential regenerative efficacy of NVs following cell hypoxic stress are poorly understood. Here, NVs were generated using rapid extrusion directly from human induced pluripotent stem cells (iPSC) under basal and hypoxic‐associated conditions, identifying select pluripotent/stem cell maintenance markers associated with NV composition. We performed adaptive cellular remodeling of iPSC to hypoxic preconditioning over 2, 4, and 6 h, demonstrating that NV form and composition are context‐dependent on hypoxia and its duration. Hypoxic exposure modifies the NV temporal protein landscape of networks involved in wound healing (FLNA, MYH9, ACTC1), hypoxia response (HMOX2, HMOX1, PGK), extracellular matrix remodeling (ITGA6, MFGE8, ITGB1), and tissue repair (HSP A5/A8/H1/20/27/70/90, GJA1, HMGB1, ILK). Importantly, we highlight that the NV proteome is dependent and highly consistent on temporal exposure of donor cells to hypoxia, indicating a platform to regulate NV phenotype, tailored toward their potency. Here, we show NVs exhibit a distinct proteome landscape associated with regulation in reactive oxygen species generation and cell/tissue survival (enhanced 2–4 h hypoxia), wound healing and angiogenesis (enhanced 4–6 h hypoxia), and tissue repair, hypoxic response, and metabolic/energy production (enhanced 6 h hypoxia). Extended hypoxic cell exposure (at 4–6 h) regulates NV function in a hypoxic time‐dependent manner, with NVs significantly promoting tubule formation of endothelial cells in hypoxic conditions ( p < 0.0001). Here, we detailed the capacity of hypoxic cell conditioning to mediate NV phenotype and function in a temporal manner as a platform to enhance functional and potential regenerative therapeutic efficacy of NVs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia.
- Baker Department of Cardiovascular Research, Translation and Implementation, La Trobe University, Melbourne, Victoria, Australia.
- Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Victoria, Australia.
- O'Brien Institute Department, St Vincent's Institute of Medical Research, Fitzroy, Victoria, Australia.
- Department of Surgery and Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- Drug Discovery Biology, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia.
Förderung
- National Heart Foundation of Australia
Zitieren
APA
Lozano, J., Rai, A., Phang, R. J., Cross, J., Lim, S. Y., & Greening, D. W. (2026). Hypoxia Modulates Nanovesicle Phenotype and Angiogenic Function From Human Pluripotent Stem Cells. PROTEOMICS, 26(7), 84-97. https://doi.org/10.1002/pmic.70129
Vancouver
Lozano J, Rai A, Phang RJ, Cross J, Lim SY, Greening DW. Hypoxia Modulates Nanovesicle Phenotype and Angiogenic Function From Human Pluripotent Stem Cells. PROTEOMICS. 2026;26(7):84-97. doi:10.1002/pmic.70129
BibTeX
@article{Lozano2026,
author = {Lozano, Jonathan and Rai, Alin and Phang, Ren J and Cross, Jonathon and Lim, Shiang Y and Greening, David W},
title = {Hypoxia Modulates Nanovesicle Phenotype and Angiogenic Function From Human Pluripotent Stem Cells},
journal = {PROTEOMICS},
year = {2026},
volume = {26},
number = {7},
pages = {84--97},
doi = {10.1002/pmic.70129}
}
EUVIMED